Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures (Q46892518)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 November 2007

edit

Language	Label	Description	Also known as
English	Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures	scientific article published on 19 November 2007

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18024209

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/18024209

title

Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18024209

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/18024209

main subject

quality of life

1 reference

based on heuristic

inferred from title

(S)-etiracetam

1 reference

based on heuristic

inferred from title

author name string

Bo Zhou

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18024209

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/18024209

Qin Zhang

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18024209

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/18024209

Linyu Tian

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18024209

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/18024209

Jun Xiao

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18024209

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/18024209

Hermann Stefan

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18024209

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/18024209

Dong Zhou

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18024209

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/18024209

publication date

19 November 2007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18024209

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/18024209

published in

Epilepsy Behavior

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18024209

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/18024209

volume

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18024209

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/18024209

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18024209

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/18024209

page(s)

305-310

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18024209

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/18024209

cites work

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

Clinically important change in quality of life in epilepsy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

Levetiracetam: preliminary experience in patients with primary brain tumours

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

The impact of epilepsy from the patient's perspective I. Descriptions and subjective perceptions

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

The impact of epilepsy from the patient's perspective II: views about therapy and health care

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

Pre-clinical evaluation of cognition enhancing drugs

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: a comparative review of newer versus older agents.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

Effects of antiepileptic drugs on attention as assessed by a five-choice serial reaction time task in rats

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

Effects of antiepileptic drugs on learning as assessed by a repeated acquisition of response sequences task in rats.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.10.003

retrieved

7 January 2021

Identifiers

DOI

10.1016/J.YEBEH.2007.10.003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18024209

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/18024209

PubMed publication ID

18024209

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18024209

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/18024209

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46892518&oldid=2136903529"